The estimated Net Worth of Vincent Capponi is at least $1.79 Million dollars as of 13 December 2023. Mr. Capponi owns over 18,797 units of Cytosorbents Corp stock worth over $584,134 and over the last 15 years he sold CTSO stock worth over $40,500. In addition, he makes $1,169,600 as Chief Operating Officer at Cytosorbents Corp.
Sign up
Mr. Capponi CTSO stock SEC Form 4 insiders trading
Vincent has made over 23 trades of the Cytosorbents Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 18,797 units of CTSO stock worth $25,000 on 13 December 2023.
The largest trade he's ever made was selling 100,000 units of Cytosorbents Corp stock on 22 January 2014 worth over $27,000. On average, Vincent trades about 10,580 units every 112 days since 2010. As of 13 December 2023 he still owns at least 584,134 units of Cytosorbents Corp stock.
You can see the complete history of Mr. Capponi stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Vincent Capponi biography
Vincent J. Capponi serves as Chief Operating Officer of the Company. Mr. Capponi joined the Company as Vice President of Operations in 2002 and became our Chief Operating Officer in July 2005. He has more than 20 years of management experience in medical device, pharmaceutical and imaging equipment at companies including Upjohn, Sims Deltec and Sabratek. Prior to joining CytoSorbents in 2002, Mr. Capponi held several senior management positions at Sabratek and its diagnostics division GDS and was interim president of GDS diagnostics in 2001. From 1998 to 2000, Mr. Capponi was Senior Vice President and Chief Operating Officer for Sabratek and Vice President Operations from 1996 to 1998. He received his M S in Chemistry and his BS in Chemistry and Microbiology from Bowling Green State University.
What is the salary of Vincent Capponi?
As the Chief Operating Officer of Cytosorbents Corp, the total compensation of Vincent Capponi at Cytosorbents Corp is $1,169,600. There are 1 executives at Cytosorbents Corp getting paid more, with Phillip Chan having the highest compensation of $1,404,380.
How old is Vincent Capponi?
Vincent Capponi is 62, he's been the Chief Operating Officer of Cytosorbents Corp since 2005. There are 6 older and 5 younger executives at Cytosorbents Corp. The oldest executive at Cytosorbents Corp is Dr. Robert H. Bartlett, 82, who is the Co-Chairman of Cardiac Surgery Advisory Board & Consultant.
What's Vincent Capponi's mailing address?
Vincent's mailing address filed with the SEC is C/O CYTOSORBENTS CORPORATION, 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540.
Insiders trading at Cytosorbents Corp
Over the last 16 years, insiders at Cytosorbents Corp have traded over $1,216,453 worth of Cytosorbents Corp stock and bought 832,447 units worth $1,058,402 . The most active insiders traders include James T. Gunton, Al Kraus, and Phillip P. Chan. On average, Cytosorbents Corp executives and independent directors trade stock every 34 days with the average trade being worth of $41,883. The most recent stock trade was executed by Alan D. Sobel on 13 December 2023, trading 22,557 units of CTSO stock currently worth $30,001.
What does Cytosorbents Corp do?
cytosorbents (nasdaq: ctso) cytosorbents corporation is a leader in critical care immunotherapy, specializing in blood purification. its flagship product, cytosorb® is approved in the european union with distribution in 40 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. these are conditions where the risk of death is extremely high, yet no effective treatments exist. cytosorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. cytosorbents' purification technologies are based on biocompatible, highly porous polymer beads
What does Cytosorbents Corp's logo look like?
Complete history of Mr. Capponi stock trades at Cytosorbents Corp
Cytosorbents Corp executives and stock owners
Cytosorbents Corp executives and other stock owners filed with the SEC include:
-
Phillip Chan,
President, Chief Executive Officer, Director -
Vincent Capponi,
Chief Operating Officer -
Kathleen Bloch,
Chief Financial Officer -
Dr. Phillip P. Chan,
CEO & Director -
Vincent J. Capponi M.S., MS,
Pres & COO -
Dr. Efthymios N. Deliargyris FACC, FESC, FSCAI, M.D.,
Chief Medical Officer -
Kathleen P. Bloch CPA, M.B.A., MBA, CPA,
CFO & Sec. -
Al Kraus,
Independent Non-Executive Chairman of the Board -
Alan Sobel,
Independent Director -
Edward Jones,
Independent Director -
Michael Bator,
Independent Director -
Dr. Robert H. Bartlett,
Co-Chairman of Cardiac Surgery Advisory Board & Consultant -
Christopher Cramer,
VP of Bus. Devel. -
Dr. Christian Steiner M.D.,
Exec. VP of Sales & Marketing -
Terri Anne Powers M.B.A.,
VP of Investor Relations & Corp. Communications -
Peter J Mariani,
Chief Financial Officer -
Eric R. Mortensen,
Chief Medical Officer -
Robert Hawes Bartlett,
Chief Medical Officer -
Investment Fund, Lp Njtc,
10% owner -
Joseph Rubin,
Director -
Ronald Berger,
Interim CFO -
James T. Gunton,
Director -
Efthymios Deliargyris,
Chief Medical Officer -
Jiny Kim,
Director